Other
Sex
0
Pipeline Programs↗
2
Active Trials↗
2
Companies Involved↗
Sex is an early-stage landscape with 0 programs across 2 companies. The most active players are Sprout Pharmaceuticals, Inc, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed7 · 54%
Unknown status2 · 15%
Terminated2 · 15%
Not yet recruiting1 · 8%
Active, not recruiting1 · 8%
Clinical Trials
Trial Activity
13 trials
Evaluation of the Index of Sexual Life Questionnaire
Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00245596·120 enrolled
Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes
Completed·—·Phase 3·NCT04921124·30 enrolled
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms
Completed·—·N/A·NCT04420533·150 enrolled
Hypoactive Sexual Desire Disorder in Males
Terminated·—·Phase 2·NCT04002661·8 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)